Then vs. Now: The History of Metformin, a Mainstay in Diabetes Treatment

Bailey, C. J. (2017). Metformin: Historical overview. Diabetologia.

Bramante, C. T., et al. (2023). Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): A multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. The Lancet Infectious Diseases.  

California Invasive Plant Council. (n.d.). Galega officinalis. 

ElSayed, N. A., et al. (2022). 14. Children and adolescents: Standards of care in diabetes—2023. Diabetes Care.

ElSayed, N. A., et al. (2022). 9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes—2023. Diabetes Care.

Goto, M., et al. (2023). Metformin and infections: What is the next step in this decades-long story? Clinical Infectious Diseases. 

Holman, R. (n.d.). UK prospective diabetes study. Radcliffe Department of Medicine.

Lipska, K. J., et al. (2016). Modifying prescribing guidelines by petitioning the FDA: The metformin experience. Circulation.

National Library of Medicine. (2023). Buformin. 

U. S. Food and Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs.

U. S. Food and Drug Administration. (2016). FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function. Drug Safety Communications. 

U. S. Food and Drug Administration. (2022). 100 years of insulin.